Logo

American Heart Association

  39
  0


Final ID: Mo2085

The Effect and Safety of Ketogenic Diets on LDL-C and other metabolic parameters compared with non-ketogenic diets among Adults with BMI Greater than 25 with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Abstract Body (Do not enter title and authors here):
OBJECTIVE
To determine the effects of a ketogenic diet on LDL-C levels and other metabolic parameters and adverse events in adults with a BMI greater than 25 and type 2 diabetes mellitus.
METHODS
A systematic review and meta-analysis of randomized controlled trials was conducted. Studies were identified through thorough searches of PubMed, Cochrane, Google Scholar, EMBASE, HERDIN. Included studies compared a ketogenic diet (≤10% carbohydrates) to a non-ketogenic diet for at least 3 months duration in adults with a BMI ≥25 and type 2 diabetes. The primary outcome was LDL-C level. Risk of bias was assessed using the Cochrane Collaboration's Risk of Bias tool and GRADE guidelines.
RESULTS
Nine studies with a total of 658 participants were included. In the short term (3-4 months), ketogenic diets significantly reduced LDL-C compared to non-ketogenic diets (mean difference: -0.16 mmol/L, 95% CI -0.31, -0.00, p = 0.04). This effect was not significant at longer follow-up periods (6-8 months, 12 months, and 24 months). Common adverse effects included hypoglycemia, constipation, and gastrointestinal discomfort.
CONCLUSION:
Ketogenic diets may offer short-term benefits in reducing LDL-C in overweight and obese adults with type 2 diabetes. However, these effects diminish over time, and the diet may be associated with adverse events. Significant short-term improvements were observed in HDL-C, triglycerides (TG), and HbA1c in ketogenic groups compared to controls, with moderate effects diminishing over time. Notably, follow-up time was a significant moderator for HDL-C, showing stronger effects at later time points, while FBS showed a borderline significant relationship with follow-up Long-term studies evaluating a broader range of metabolic outcomes are needed.
  • Supe, Anya Francheska  ( Cardinal Santos Medical Center , Quezon City , Philippines )
  • San Juan, Albert  ( Cardinal Santos Medical Center , Quezon City , Philippines )
  • Sy, Rosa  ( CARDINAL SANTOS MEDICAL CENTER , Metro Manila , Philippines )
  • Chiu, Harold Henrison  ( Cardinal Santos Medical Center , Quezon City , Philippines )
  • Author Disclosures:
    Anya Francheska Supe: DO NOT have relevant financial relationships | Albert San Juan: DO NOT have relevant financial relationships | Rosa Sy: No Answer | Harold Henrison Chiu: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiovascular Nutrition: From Nutrients to Dietary Patterns

Monday, 11/10/2025 , 10:30AM - 11:30AM

Abstract Poster Board Session

More abstracts on this topic:
ALDH2 rs671 polymorphism and metabolic signatures in patients with cardiovascular diseases

Zeng Linqi

A 3-Year, Pre-Trial, Real-world Data Analysis of Patients Enrolled in VICTORION-INITIATE: Insights Using Tokenization

Rodriguez Fatima, Cosmatos Irene, Desai Nihar, Wright R, Ross Elsie, Ali Yousuf, Kumar Biswajit, Han Guangyang, Cai Beilei, Abbas Cheryl, Ryan Amy

You have to be authorized to contact abstract author. Please, Login
Not Available